-
1دورية أكاديمية
المؤلفون: Musallam KM; Center for Research on Rare Blood Disorders (CR-RBD), Burjeel Medical City, Abu Dhabi, United Arab Emirates; Division of Hematology/Oncology, Department of Pediatrics, Weill Cornell Medicine, New York, NY, USA., Barella S; S.C. Centro delle Microcitemie e Anemie Rare, ASL Cagliari, Cagliari, Italy., Origa R; Università di Cagliari, S.C. Centro delle Microcitemie e Anemie Rare, ASL Cagliari, Cagliari, Italy., Ferrero GB; Hemoglobinopathies and Rare Anemia Reference Center, San Luigi Gonzaga University Hospital, Department of Biological and Clinical Sciences, University of Turin, Turin, Italy., Lisi R; Thalassemia Unit, ARNAS Garibaldi, Catania, Italy., Pasanisi A; Centro della Microcitemia A.Quarta, Hematology Unit, A. Perrino Hospital, Brindisi, Italy., Longo F; Day Hospital della Talassemia e delle Emoglobinopatie, Azienda Ospedaliero Universitaria S. Anna, Ferrara, Italy., Gianesin B; ForAnemia Foundation, Genoa, Italy., Forni GL; ForAnemia Foundation, Genoa, Italy. Electronic address: gianlucaforni14@gmail.com.
مؤلفون مشاركون: Webthal® project
المصدر: Blood cells, molecules & diseases [Blood Cells Mol Dis] 2024 Jul; Vol. 107, pp. 102859. Date of Electronic Publication: 2024 May 29.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Academic Press Country of Publication: United States NLM ID: 9509932 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-0961 (Electronic) Linking ISSN: 10799796 NLM ISO Abbreviation: Blood Cells Mol Dis Subsets: MEDLINE
مواضيع طبية MeSH: Iron Chelating Agents*/therapeutic use , beta-Thalassemia*/mortality , beta-Thalassemia*/therapy , beta-Thalassemia*/drug therapy , beta-Thalassemia*/complications , Deferoxamine*/therapeutic use , Deferiprone*/therapeutic use , Iron*/metabolism , Deferasirox*/therapeutic use , Pyridones*/therapeutic use , Blood Transfusion*, Humans ; Female ; Male ; Adult ; Retrospective Studies ; Iron Overload/etiology ; Iron Overload/drug therapy ; Benzoates/therapeutic use ; Ferritins/blood ; Adolescent ; Triazoles/therapeutic use ; Young Adult ; Child ; Treatment Outcome ; Middle Aged ; Liver/metabolism ; Liver/drug effects ; Liver/pathology ; Cohort Studies